IONIS PHARMACEUTICALS INC - 8-K Filing
FDA approves ZANVASTRO (zilganersen) as first disease-modifying treatment for Alexander disease in pediatric and adult patients (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $IONS